| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adb0e564374fedf34b36103d36e6455a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f60544ac130e6793868b07cfdf836506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c847755d3d823d20ff87324f4b408daf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7edfa63c8fac4cf0da2f56d505e7e8fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 |
| filingDate |
2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf0ac68e5e19875912ca39359248f0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79855a6eb4781f31c1bf86cf25a52271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffcf35de85a8387c6abd2025cb1826fc |
| publicationDate |
2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006089921-A1 |
| titleOfInvention |
Blood pressure lowering peptides from glycomacropeptide |
| abstract |
A process to produce IPP from a protein source whereby the protein source comprises a protein having the -I-P-P- sequence and having in the protein amino acid sequence at least 6 times more -I-P-P- present than -V-P-P- (molar basis) which comprises hydrolysing the protein source to liberate at least 40% of the I-P-P- sequence 10 into the peptide IPP and whereby a proteolytic enzyme is used which cleaves at the carboxy-terminus of proline residues present in the protein source, the enzyme is preferably a proline specific endoprotease or proline specific oligopeptidase, more preferably a proline specific endoprotease, and optionally an amino peptidase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7879804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006067163-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009057725-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006067163-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7785824-B2 |
| priorityDate |
2005-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |